Sample Treatment with Trypsin for RT-LAMP COVID-19 Diagnosis
The SARS-CoV-2 coronavirus is responsible for the COVID-19 pandemic resulting in a global health emergency. Given its rapid spread and high number of infected individuals, a diagnostic tool for a rapid, simple, and cost-effective detection was essential. In this work, we developed a COVID-19 diagnostic test, that incorporates a human internal control, based on the Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP). When working with synthetic SARS-CoV-2 RNA, the optimized RT-LAMP assay has a sensitivity of 10 viral copies and can be detected by fluorescence in less than 15 min or by the naked eye in 25 min using colorimetric RT-LAMP. To avoid the RNA extraction step, a pre-treatment of the sample was optimized. Subsequently, a validation was performed on 268 trypsin treated samples (including nasopharyngeal, buccal, and nasal exudates) and amplified with colorimetric RT-LAMP to evaluate its sensitivity and specificity in comparison with RT-qPCR of extracted samples. The validation results showed a sensitivity and specificity of 100% for samples with Ct ≤ 30. The rapid, simple, and inexpensive RT-LAMP SARS-CoV-2 extraction-free procedure developed may be an alternative test that could be applied for the detection of SARS-CoV-2 or adapted to detect other viruses present in saliva or nasopharyngeal samples with higher sensitivity and specificity of the antibody test.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Biology - 12(2023), 7 vom: 23. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
García-Sorribes, Soraya [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 31.07.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/biology12070900 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360082033 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360082033 | ||
003 | DE-627 | ||
005 | 20231226082243.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/biology12070900 |2 doi | |
028 | 5 | 2 | |a pubmed24n1200.xml |
035 | |a (DE-627)NLM360082033 | ||
035 | |a (NLM)37508333 | ||
035 | |a (PII)900 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a García-Sorribes, Soraya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Sample Treatment with Trypsin for RT-LAMP COVID-19 Diagnosis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 31.07.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a The SARS-CoV-2 coronavirus is responsible for the COVID-19 pandemic resulting in a global health emergency. Given its rapid spread and high number of infected individuals, a diagnostic tool for a rapid, simple, and cost-effective detection was essential. In this work, we developed a COVID-19 diagnostic test, that incorporates a human internal control, based on the Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP). When working with synthetic SARS-CoV-2 RNA, the optimized RT-LAMP assay has a sensitivity of 10 viral copies and can be detected by fluorescence in less than 15 min or by the naked eye in 25 min using colorimetric RT-LAMP. To avoid the RNA extraction step, a pre-treatment of the sample was optimized. Subsequently, a validation was performed on 268 trypsin treated samples (including nasopharyngeal, buccal, and nasal exudates) and amplified with colorimetric RT-LAMP to evaluate its sensitivity and specificity in comparison with RT-qPCR of extracted samples. The validation results showed a sensitivity and specificity of 100% for samples with Ct ≤ 30. The rapid, simple, and inexpensive RT-LAMP SARS-CoV-2 extraction-free procedure developed may be an alternative test that could be applied for the detection of SARS-CoV-2 or adapted to detect other viruses present in saliva or nasopharyngeal samples with higher sensitivity and specificity of the antibody test | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a RNA extraction-free | |
650 | 4 | |a RT-LAMP | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a colorimetry | |
650 | 4 | |a trypsin | |
700 | 1 | |a Lara-Hernández, Francisco |e verfasserin |4 aut | |
700 | 1 | |a Manzano-Blasco, Iris |e verfasserin |4 aut | |
700 | 1 | |a Abadía-Otero, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Albert, Eliseo |e verfasserin |4 aut | |
700 | 1 | |a Mulet, Alba |e verfasserin |4 aut | |
700 | 1 | |a Briongos-Figuero, Laisa Socorro |e verfasserin |4 aut | |
700 | 1 | |a Gabella-Martín, Miriam |e verfasserin |4 aut | |
700 | 1 | |a Torres, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Signes-Costa, Jaime |e verfasserin |4 aut | |
700 | 1 | |a Navarro, David |e verfasserin |4 aut | |
700 | 1 | |a Martín-Escudero, Juan-Carlos |e verfasserin |4 aut | |
700 | 1 | |a García-García, Ana-Bárbara |e verfasserin |4 aut | |
700 | 1 | |a Chaves, Felipe Javier |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biology |d 2011 |g 12(2023), 7 vom: 23. Juni |w (DE-627)NLM220614288 |x 2079-7737 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2023 |g number:7 |g day:23 |g month:06 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/biology12070900 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2023 |e 7 |b 23 |c 06 |